Monrsouir, France

Gérard Benoit

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gérard Benoit. Retrieved from https://idiyas.com/inventor/gandeacuterard-benoit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gérard Benoit: Innovator in Hyperproliferative Disease Treatment

Introduction

Gérard Benoit is a notable inventor based in Monrsouir, France. He has made significant contributions to the field of medical treatments, particularly in addressing hyperproliferative diseases. His innovative approach combines advanced biochemistry with therapeutic applications.

Latest Patents

Gérard Benoit holds 1 patent for his invention titled "Compositions and methods for treatment of hyperproliferative diseases." This patent relates to compositions that include a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention outlines methods for treating hyperproliferative diseases through the administration of these compounds.

Career Highlights

Throughout his career, Gérard Benoit has focused on developing effective treatments for complex medical conditions. His work has been instrumental in advancing the understanding of hyperproliferative diseases and their management.

Collaborations

Gérard has collaborated with esteemed colleagues in his field, including Hinrich Gronemeyer and Michel Lanotte. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Gérard Benoit is a distinguished inventor whose work in the treatment of hyperproliferative diseases showcases his commitment to medical innovation. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…